People with OCD reported a reduction in the symptoms within four hours of smoking cannabis, a new study reports.
Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19.
Cannabidiol (CBD) increases cerebral blood flow to areas of the brain associated with memory processing, specifically the hippocampus. The findings identify a potential mechanism for the use of CBD to treat disorders associated with altered memory processing, including Alzheimer's disease, PTSD, and schizophrenia.
Cannabis reduces the severity of symptoms by more than half in the short-term for people suffering from PTSD. Using cannabis reduces recurring thoughts of a traumatic event by 62%, flashbacks by 51%, irritability by 67%, and anxiety by 57% for those with PTSD. However, the reduction of symptoms is not permanent.
Cannabidiol (CBD) appears to slow the growth of glioblastoma brain cancer cells in both animal and human cell lines. CBD's anti-cancer actions target mitochondria, causing them to dysfunction and release harmful reactive oxygen species. Cancer cells treated with CBD exhibited significant decreases in mitochondrial activity.
Using purified botanical cannabidiol (CBD) to treat mouse models of Davet syndrome improved mortality and reduced behavioral symptoms associated with the condition.
Many cannabis users don't know how much THC or CBD is considered an effective dose.
Analyzing the results of 15 different studies involving over 300 subjects, researchers discovered a single dose of THC could induce psychiatric symptoms in people with no history of psychosis.